Skip to content
MedsAcross

Medicine

Hepzato Kit kit

Melphalan hydrochloride injection · Intra-arterial · Delcath Systems
Available on requestPrescription onlyUS FDA

Hepzato Kit kit is a prescription medicine containing Melphalan hydrochloride injection for intra-arterial use, marketed by Delcath Systems, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

HEPZATO for injection and its associated diluents including 0.9% sodium…

Key facts

Active ingredient (INN)
Melphalan hydrochloride injection
Brand
Hepzato Kit
Dosage form
Kit
Route
Intra-arterial
Packs
1 kit
Marketing authorisation holder
Delcath Systems
Manufacturer
Delcath Systems
Origin register
US FDA, United States
Storage
HEPZATO for injection and its associated diluents including 0.9% sodium chloride must be stored at controlled room temperature 20°C to 25°C (68°F to 77°F). Temperature excursions are permitted between 15°C- 30°C (59°F-86°F). The Hepatic Delivery System components may be stored at room temperature.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
4 December 2023
Identifiers
RxCUI 311487, 2671196DailyMed set ID 4f83c8f7-4cc0-4219-88d5-7cfddce91198NDC 75833-601Application NDA201848

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

PackCodeLabelerMarketed since
1 kit in 1 box * 5 vial, single-use in 1 box / 10 mL in 1 vial, single-use * 2 bag in 1 box / 250 mL in 1 bag * 5 vial, single-use in 1 box / 10 mL in 1 vial, single-use75833-601-01Delcath Systems4 December 2023
1 kit in 1 box * 5 vial, single-use in 1 box / 10 mL in 1 vial, single-use * 2 bag in 1 box / 250 mL in 1 bag * 5 vial, single-use in 1 box / 10 mL in 1 vial, single-use75833-601-02Delcath Systems4 December 2023

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Clinical summary

Melphalan hydrochloride injection is a prescription medicine. It is available as kits for intra-arterial use. MedsAcross supplies Melphalan hydrochloride injection for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Melphalan hydrochloride injection

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Hepzato Kit kit for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.